Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul 30;25(15):8311.
doi: 10.3390/ijms25158311.

New Advances in Metabolic Syndrome

Manfredi Rizzo  1 , Ali A Rizvi  2
Affiliations
Editorial

New Advances in Metabolic Syndrome

Manfredi Rizzo et al. Int J Mol Sci. .

Abstract

It is with great anticipation and pride that we present a Special Issue entitled "New Advances in Metabolic Syndrome", which provides a compendium of high-quality original papers written on novel aspects of metabolic syndrome (MetS) [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no relevant conflicts of interest.

Figures

Figure 1
Figure 1
Mechanisms highlighting the pathophysiology of the metabolic syndrome (from ref. [5]: Fahed et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 2022, 23, 786. Open access, available at https://doi.org/10.3390/ijms23020786).
See this image and copyright information in PMC

References

    1. Saklayen M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018;20:12. doi: 10.1007/s11906-018-0812-z. - DOI - PMC - PubMed
    1. Gesteiro E., Megía A., Guadalupe-Grau A., Fernandez-Veledo S., Vendrell J., González-Gross M. Early identification of metabolic syndrome risk: A review of reviews and proposal for defining pre-metabolic syndrome status. Nutr. Metab. Cardiovasc. Dis. 2021;31:2557–2574. doi: 10.1016/j.numecd.2021.05.022. - DOI - PubMed
    1. Kao T.W., Huang C.C. Recent Progress in Metabolic Syndrome Research and Therapeutics. Int. J. Mol. Sci. 2021;22:6862. doi: 10.3390/ijms22136862. - DOI - PMC - PubMed
    1. Nasoohi S., Parveen K., Ishrat T. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer’s Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers. J. Alzheimer’s Dis. 2018;66:857–885. doi: 10.3233/JAD-180735. - DOI - PubMed
    1. Fahed G., Aoun L., Bou Zerdan M., Allam S., Bou Zerdan M., Bouferraa Y., Assi H.I. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 2022;23:786. doi: 10.3390/ijms23020786. - DOI - PMC - PubMed

Publication types

LinkOut - more resources